Search

everythinglearnresearchcommunity

for

Search:↓

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Trichothiodystrophy can be linked to urologic issues and high calcium in urine.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Patients with thyroid disorders show different symptoms and antibody levels.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

GI197111X is best dissolved in Capmul MCM for trials.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Metyrapone can effectively treat Cushing's Disease even if the mass causing it is not found.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Some drugs for inflammation may cause psoriasis-like hair loss.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

TGF-β1 and TNF-α contribute to lung damage after radiation.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.